Updated · GMP, subscription and listing data refresh through the day.
Detailed financials for this issue aren’t available yet.
| Application | Shares | Amount at ₹67 |
|---|---|---|
| Individual investor (min)minimum application | 4,000 | ₹2,68,000 |
The minimum application is 4,000 shares, ₹2,68,000 at the ₹67 cut-off. Since 1 July 2025 SME issues take a minimum application of ₹2,00,000 or more from individual investors; the HNI minimum is set in the RHP. Amounts are shown at the upper band because applications are made at the cut-off price.
Quanto Agroworld Limited is engaged in the cultivation, processing, and supply of Medicinal and Aromatic Plants (MAPs), with lemongrass as its primary crop. The company manufactures essential oils and botanical biomass formats. Its business model is vertically integrated, covering agricultural cultivation to primary processing and bulk supply, serving institutional and business-to-business customers across India.
The draft red herring prospectus is filed with SEBI before the issue; the red herring prospectus adds the price band and dates just before bidding opens. Both describe the business, the restated financials, the risk factors and how the proceeds will be used.
Allotment is decided and published by the issue’s registrar, not by the exchange and not by alphave. For Quanto Agroworld, the registrar is MUFG Intime India Pvt. Ltd. — allotment is finalised in the days between the issue closing on 17 Sept 2026 and listing on 22 Sept 2026.
Allotment and refund dates follow SEBI’s T+3 listing timeline in trading days and are tentative until the registrar and the exchange confirm them. alphave does not hold allotment results — only the registrar can show whether an application was allotted.
The registrar publishes allotment on its own portal: MUFG Intime. Your bank will also show the blocked amount released if shares were not allotted.
The offer document for the Quanto Agroworld IPO is linked on this page as filed with the exchange; SEBI and the lead managers also host it.
The Draft Red Herring Prospectus is the document a company files with SEBI before an IPO. It describes the business, the financials, the risk factors, the promoters and how the money raised will be used. The Red Herring Prospectus (RHP) is the version filed just before the issue opens, with the price band and dates added.
Integrated operations across cultivation, harvesting, distillation, and processing. Access to a large cultivation cluster with on-site distillation. Sustainable, zero-waste operating model with by-product utilization. The page lists all 5 as disclosed.
Inability to collect trade receivables from customers in a timely manner could adversely affect business, results of operations, cash flows, and financial condition. The company has previously compounded a non-compliance under the Companies Act, 2013, which may have regulatory and reputational implications. A significant portion of purchases has been undertaken from a related party, and any adverse developments affecting such related party or the relationship with them may adversely affect business operations and financial condition. The page lists all 7 disclosed risk factors.
The registrar processes the allotment and the refunds. Contact details are as printed in the offer document; the exchange and your broker cannot change an allotment.
Grey Market Premium is the price at which an unlisted IPO application or share changes hands informally, before the stock is listed on the exchange. It is quoted as a rupee figure over the issue price: a premium of ₹0 on a ₹67 upper band means the grey market is dealing at ₹67.
The grey market is an over-the-counter market between private dealers. It is not operated or supervised by NSE, BSE or SEBI, no trade is settled through a clearing corporation, and no dealer is obliged to publish or honour a quote. Figures are collected by third-party reporters and different sources routinely disagree, which is why a premium can move sharply within a day or vanish entirely once bidding closes.
Grey Market Premium is an unofficial, unregulated over-the-counter datapoint reported by third parties. It is not a price, a forecast, or an indication of listing gains, and is not investment advice.